Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	immunoglobulin receptor binding	IGHA1 IGHA2 IGHG3	1.85e-04	21	107	3	GO:0034987
GeneOntologyMolecularFunction	DNA-binding transcription activator activity, RNA polymerase II-specific	FOXN1 RREB1 PRDM2 FOSL1 HOXA5 NFATC1 KLF13 ZNF358 FOXH1 HSF1 NOTCH4	2.08e-04	560	107	11	GO:0001228
GeneOntologyMolecularFunction	DNA-binding transcription activator activity	FOXN1 RREB1 PRDM2 FOSL1 HOXA5 NFATC1 KLF13 ZNF358 FOXH1 HSF1 NOTCH4	2.28e-04	566	107	11	GO:0001216
GeneOntologyCellularComponent	dimeric IgA immunoglobulin complex	IGHA1 IGHA2	7.33e-05	3	104	2	GO:0071750
GeneOntologyCellularComponent	secretory dimeric IgA immunoglobulin complex	IGHA1 IGHA2	7.33e-05	3	104	2	GO:0071752
GeneOntologyCellularComponent	immunoglobulin complex, circulating	IGHA1 IGHA2 IGHG3	7.73e-05	17	104	3	GO:0042571
GeneOntologyCellularComponent	extracellular matrix	NID2 MUC5B APOH FCGBP IGFBP7 ADAMTSL5 ADAMTS7 MMP9 MUC5AC MUC6 CCN3 OTOG	1.02e-04	656	104	12	GO:0031012
GeneOntologyCellularComponent	external encapsulating structure	NID2 MUC5B APOH FCGBP IGFBP7 ADAMTSL5 ADAMTS7 MMP9 MUC5AC MUC6 CCN3 OTOG	1.05e-04	658	104	12	GO:0030312
GeneOntologyCellularComponent	monomeric IgA immunoglobulin complex	IGHA1 IGHA2	8.63e-04	9	104	2	GO:0071748
GeneOntologyCellularComponent	polymeric IgA immunoglobulin complex	IGHA1 IGHA2	1.07e-03	10	104	2	GO:0071749
GeneOntologyCellularComponent	IgA immunoglobulin complex, circulating	IGHA1 IGHA2	1.07e-03	10	104	2	GO:0071746
GeneOntologyCellularComponent	secretory IgA immunoglobulin complex	IGHA1 IGHA2	1.07e-03	10	104	2	GO:0071751
Domain	TIL	MUC5B FCGBP MUC5AC MUC6 OTOG	3.73e-09	12	104	5	PF01826
Domain	C8	MUC5B FCGBP MUC5AC MUC6 OTOG	3.73e-09	12	104	5	PF08742
Domain	Unchr_dom_Cys-rich	MUC5B FCGBP MUC5AC MUC6 OTOG	6.04e-09	13	104	5	IPR014853
Domain	C8	MUC5B FCGBP MUC5AC MUC6 OTOG	6.04e-09	13	104	5	SM00832
Domain	TIL_dom	MUC5B FCGBP MUC5AC MUC6 OTOG	9.35e-09	14	104	5	IPR002919
Domain	VWD	MUC5B FCGBP MUC5AC MUC6 OTOG	2.02e-08	16	104	5	SM00216
Domain	VWF_type-D	MUC5B FCGBP MUC5AC MUC6 OTOG	2.02e-08	16	104	5	IPR001846
Domain	VWFD	MUC5B FCGBP MUC5AC MUC6 OTOG	2.02e-08	16	104	5	PS51233
Domain	VWD	MUC5B FCGBP MUC5AC MUC6 OTOG	2.02e-08	16	104	5	PF00094
Domain	VWC_out	MUC5B FCGBP MUC5AC MUC6 OTOG	5.31e-08	19	104	5	SM00215
Domain	VWF_dom	MUC5B FCGBP MUC5AC MUC6 CCN3 OTOG	1.15e-07	42	104	6	IPR001007
Domain	CT	MUC5B MUC5AC MUC6 CCN3 OTOG	1.19e-07	22	104	5	SM00041
Domain	Cys_knot_C	MUC5B MUC5AC MUC6 CCN3 OTOG	2.36e-07	25	104	5	IPR006207
Domain	CTCK_2	MUC5B MUC5AC MUC6 CCN3 OTOG	2.36e-07	25	104	5	PS01225
Domain	VWC	MUC5B FCGBP MUC5AC CCN3	5.79e-05	38	104	4	SM00214
Domain	NPIP	NPIPA7 NPIPB13 NPIPA2	5.84e-05	14	104	3	IPR009443
Domain	Glyco_hormone_CN	MUC5B MUC5AC CCN3	7.27e-05	15	104	3	IPR006208
Domain	Cys_knot	MUC5B MUC5AC CCN3	7.27e-05	15	104	3	PF00007
Domain	CTCK_1	MUC5B MUC5AC CCN3	1.29e-04	18	104	3	PS01185
Domain	FAD-bd	MICAL2 MICAL3	4.54e-04	6	104	2	IPR002938
Domain	FAD_binding_3	MICAL2 MICAL3	4.54e-04	6	104	2	PF01494
Domain	WxxW_domain	MUC5B MUC5AC	4.54e-04	6	104	2	IPR025155
Domain	Mucin2_WxxW	MUC5B MUC5AC	4.54e-04	6	104	2	PF13330
Domain	VWC	MUC5B MUC5AC CCN3	4.97e-04	28	104	3	PF00093
Domain	VWFC_1	MUC5B MUC5AC CCN3	1.05e-03	36	104	3	PS01208
Domain	VWFC_2	MUC5B MUC5AC CCN3	1.23e-03	38	104	3	PS50184
Domain	Growth_fac_rcpt_	NID2 IGFBP7 MEGF8 NOTCH4 CCN3	1.80e-03	156	104	5	IPR009030
Domain	EGF_3	NID2 MEGF8	1.95e-03	12	104	2	PF12947
Domain	EGF_dom	NID2 MEGF8	1.95e-03	12	104	2	IPR024731
Domain	LDLRA_1	CD320 PKD1 LRP3	2.42e-03	48	104	3	PS01209
Domain	LDLRA_2	CD320 PKD1 LRP3	2.57e-03	49	104	3	PS50068
Domain	FH2	GRID2IP FHDC1	3.08e-03	15	104	2	PS51444
Domain	FH2_Formin	GRID2IP FHDC1	3.08e-03	15	104	2	IPR015425
Domain	FH2	GRID2IP FHDC1	3.08e-03	15	104	2	PF02181
Domain	FH2	GRID2IP FHDC1	3.08e-03	15	104	2	SM00498
Domain	C1-set	IGHA1 IGHA2 IGHG3	3.39e-03	54	104	3	PF07654
Domain	IGc1	IGHA1 IGHA2 IGHG3	3.75e-03	56	104	3	SM00407
Domain	C1_1	MYO9B DGKZ RASGRP2	3.95e-03	57	104	3	PF00130
Domain	LCE	LCE3C LCE5A	3.95e-03	17	104	2	PF14672
Domain	LCE	LCE3C LCE5A	3.95e-03	17	104	2	IPR028205
Domain	Ig_C1-set	IGHA1 IGHA2 IGHG3	4.14e-03	58	104	3	IPR003597
Domain	Ig/MHC_CS	IGHA1 IGHA2 IGHG3	4.14e-03	58	104	3	IPR003006
Domain	IB	IGFBP7 CCN3	4.43e-03	18	104	2	SM00121
Domain	IG_MHC	IGHA1 IGHA2 IGHG3	4.56e-03	60	104	3	PS00290
Domain	TSP_1	ADAMTSL5 ADAMTS7 CCN3	5.23e-03	63	104	3	PF00090
Domain	ZF_DAG_PE_1	MYO9B DGKZ RASGRP2	5.46e-03	64	104	3	PS00479
Domain	ZF_DAG_PE_2	MYO9B DGKZ RASGRP2	5.46e-03	64	104	3	PS50081
Domain	IGFBP-like	IGFBP7 CCN3	5.47e-03	20	104	2	IPR000867
Domain	IGFBP	IGFBP7 CCN3	5.47e-03	20	104	2	PF00219
Domain	IGFBP_N_2	IGFBP7 CCN3	5.47e-03	20	104	2	PS51323
Domain	C1	MYO9B DGKZ RASGRP2	5.70e-03	65	104	3	SM00109
Domain	TSP1	ADAMTSL5 ADAMTS7 CCN3	5.70e-03	65	104	3	SM00209
Domain	TSP1_rpt	ADAMTSL5 ADAMTS7 CCN3	5.70e-03	65	104	3	IPR000884
Domain	TSP1	ADAMTSL5 ADAMTS7 CCN3	5.70e-03	65	104	3	PS50092
Domain	PE/DAG-bd	MYO9B DGKZ RASGRP2	5.95e-03	66	104	3	IPR002219
Pathway	REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS	MUC5B ADAMTSL5 ADAMTS7 MUC5AC MUC6 NOTCH4	1.44e-06	68	74	6	M27303
Pathway	REACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC	MUC5B MUC5AC MUC6	7.40e-05	16	74	3	M27410
Pathway	REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS	MUC5B MUC5AC MUC6	8.96e-05	17	74	3	M27412
Pathway	REACTOME_DISEASES_OF_GLYCOSYLATION	MUC5B ADAMTSL5 ADAMTS7 MUC5AC MUC6 NOTCH4	1.03e-04	143	74	6	M27275
Pathway	REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS	MUC5B MUC5AC MUC6	1.73e-04	21	74	3	MM15706
Pathway	REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS	MUC5B MUC5AC MUC6	2.28e-04	23	74	3	M556
Pathway	REACTOME_O_LINKED_GLYCOSYLATION	MUC5B ADAMTSL5 ADAMTS7 MUC5AC MUC6	2.66e-04	109	74	5	MM15164
Pathway	REACTOME_O_LINKED_GLYCOSYLATION	MUC5B ADAMTSL5 ADAMTS7 MUC5AC MUC6	2.89e-04	111	74	5	M27416
Pathway	REACTOME_DECTIN_2_FAMILY	MUC5B MUC5AC MUC6	3.31e-04	26	74	3	M27483
Pathway	REACTOME_DISEASES_OF_METABOLISM	MUC5B CD320 ADAMTSL5 ADAMTS7 MUC5AC MUC6 NOTCH4	3.32e-04	250	74	7	M27554
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	SEMA6C NCOA6 TBKBP1 MYO9B PPRC1 PEX6 C15orf39 SRCAP HES2 HIVEP3 ZCCHC14 NHSL1 MAP1S SLC16A5 MEGF8 ADAMTSL5 NFATC1 ADAMTS7 A4GALT EIF4G1 PKD1 LRP3 DISP2 MICAL3 BAHCC1	1.18e-14	1105	112	25	35748872
Pubmed	Expression of MUC2, MUC5AC, MUC5B, and MUC6 mucins in colorectal cancers and their association with the CpG island methylator phenotype.	MUC5B MUC5AC MUC6	1.30e-07	4	112	3	23807779
Pubmed	Epigenetic regulation (DNA methylation, histone modifications) of the 11p15 mucin genes (MUC2, MUC5AC, MUC5B, MUC6) in epithelial cancer cells.	MUC5B MUC5AC MUC6	1.30e-07	4	112	3	17471237
Pubmed	The mouse secreted gel-forming mucin gene cluster.	MUC5B MUC5AC MUC6	1.30e-07	4	112	3	14984930
Pubmed	Effects of the Helicobacter pylori Virulence Factor CagA and Ammonium Ion on Mucins in AGS Cells.	MUC5B MUC5AC MUC6	1.30e-07	4	112	3	29869461
Pubmed	Characterization of mouse muc6 and evidence of conservation of the gel-forming mucin gene cluster between human and mouse.	MUC5B MUC5AC MUC6	1.30e-07	4	112	3	12676567
Pubmed	Expression of Muc19/Smgc gene products during murine sublingual gland development: cytodifferentiation and maturation of salivary mucous cells.	MUC5B MUC5AC MUC6	6.46e-07	6	112	3	19110483
Pubmed	A proteomic analysis of human bile.	APOH FCGBP IGHA1 IGHA2	7.13e-07	22	112	4	15084671
Pubmed	Otogelin, otogelin-like, and stereocilin form links connecting outer hair cell stereocilia to each other and the tectorial membrane.	STRC STRCP1 OTOG	5.26e-06	11	112	3	31776257
Pubmed	Genetic variants associated with idiopathic pulmonary fibrosis susceptibility and mortality: a genome-wide association study.	MAPT MUC5B MUC5AC	5.26e-06	11	112	3	24429156
Pubmed	A census of human transcription factors: function, expression and evolution.	FOXN1 RREB1 HES2 PRDM2 FOSL1 HOXA5 HIVEP3 TGIF1 NFATC1 KLF13 TSHZ1 FOXH1 HSF1	7.55e-06	908	112	13	19274049
Pubmed	Identification of N-linked glycoproteins in human saliva by glycoprotein capture and mass spectrometry.	MUC5B APOH FCGBP IGHA2	9.41e-06	41	112	4	16740002
Pubmed	Cloning and analysis of cDNA encoding a major airway glycoprotein, human tracheobronchial mucin (MUC5).	MUC5B MUC5AC	1.03e-05	2	112	2	7513696
Pubmed	The association between MUC5AC and MUC5B genes expression and remodeling progression in severe neutrophilic asthma: A direct relationship.	MUC5B MUC5AC	1.03e-05	2	112	2	37146737
Pubmed	MUC5AC and MUC5B Mucins Are Decreased in Cystic Fibrosis Airway Secretions.	MUC5B MUC5AC	1.03e-05	2	112	2	14988081
Pubmed	Mucin glycosylation changes in cystic fibrosis lung disease are not manifest in submucosal gland secretions.	MUC5B MUC5AC	1.03e-05	2	112	2	15563276
Pubmed	The expression of MUC5AC and MUC5B mucin genes in the mucosa of chronic rhinosinusitis and nasal polyposis.	MUC5B MUC5AC	1.03e-05	2	112	2	17621824
Pubmed	Muc5b is required for airway defence.	MUC5B MUC5AC	1.03e-05	2	112	2	24317696
Pubmed	Macrophages are related to goblet cell hyperplasia and induce MUC5B but not MUC5AC in human bronchus epithelial cells.	MUC5B MUC5AC	1.03e-05	2	112	2	22391959
Pubmed	Mucins MUC5AC and MUC5B Are Variably Packaged in the Same and in Separate Secretory Granules.	MUC5B MUC5AC	1.03e-05	2	112	2	35776514
Pubmed	Retinoblastoma protein-interacting zinc finger 1 (RIZ1) participates in RANKL-induced osteoclast formation via regulation of NFATc1 expression.	PRDM2 NFATC1	1.03e-05	2	112	2	20417662
Pubmed	The ocular surface phenotype of Muc5ac and Muc5b null mice.	MUC5B MUC5AC	1.03e-05	2	112	2	24327612
Pubmed	Control of bone resorption in mice by Schnurri-3.	HIVEP3 NFATC1	1.03e-05	2	112	2	22573816
Pubmed	Analysis of the Relationship Between Metalloprotease-9 and Tau Protein in Alzheimer's Disease.	MAPT MMP9	1.03e-05	2	112	2	32538846
Pubmed	Clinicopathological features of superficial non-ampurally duodenal epithelial tumor; gastric phenotype of histology correlates to higher malignant potency.	MUC5AC MUC6	1.03e-05	2	112	2	28321513
Pubmed	Gel-forming mucins form distinct morphologic structures in airways.	MUC5B MUC5AC	1.03e-05	2	112	2	28607090
Pubmed	Src homology 2-containing protein tyrosine phosphatase-2 acts as a negative regulator for MUC5AC transcription via the inhibition of the ERK1/2 MAPK signalling pathway in the airway.	PTPN11 MUC5AC	1.03e-05	2	112	2	23582017
Pubmed	Muc5b is mainly expressed and sialylated in the nasal olfactory epithelium whereas Muc5ac is exclusively expressed and fucosylated in the nasal respiratory epithelium.	MUC5B MUC5AC	1.03e-05	2	112	2	31030254
Pubmed	LPS-stimulated MUC5AC production involves Rac1-dependent MMP-9 secretion and activation in NCI-H292 cells.	MMP9 MUC5AC	1.03e-05	2	112	2	19501047
Pubmed	The idiopathic pulmonary fibrosis honeycomb cyst contains a mucocilary pseudostratified epithelium.	MUC5B MUC5AC	1.03e-05	2	112	2	23527003
Pubmed	Up-regulation of MUC5AC and MUC5B mucin genes in nasopharyngeal respiratory mucosa and selective up-regulation of MUC5B in middle ear in pediatric otitis media with effusion.	MUC5B MUC5AC	1.03e-05	2	112	2	16540890
Pubmed	Dual-vector gene therapy restores cochlear amplification and auditory sensitivity in a mouse model of DFNB16 hearing loss.	STRC STRCP1	1.03e-05	2	112	2	34910522
Pubmed	Abnormalities in MUC5AC and MUC5B Protein in Airway Mucus in Asthma.	MUC5B MUC5AC	1.03e-05	2	112	2	27845589
Pubmed	Contribution of mucus concentration and secreted mucins Muc5ac and Muc5b to the pathogenesis of muco-obstructive lung disease.	MUC5B MUC5AC	1.03e-05	2	112	2	27435107
Pubmed	MMP-9 and MMP-2 Contribute to Neuronal Cell Death in iPSC Models of Frontotemporal Dementia with MAPT Mutations.	MAPT MMP9	1.03e-05	2	112	2	27594586
Pubmed	Mucins MUC5B and MUC5AC in Distal Airways and Honeycomb Spaces: Comparison among Idiopathic Pulmonary Fibrosis/Usual Interstitial Pneumonia, Fibrotic Nonspecific Interstitial Pneumonitis, and Control Lungs.	MUC5B MUC5AC	1.03e-05	2	112	2	26871672
Pubmed	Gastric MUC5AC and MUC6 are large oligomeric mucins that differ in size, glycosylation and tissue distribution.	MUC5AC MUC6	1.03e-05	2	112	2	11988092
Pubmed	Rhinovirus-induced MMP-9 expression is dependent on Fra-1, which is modulated by formoterol and dexamethasone.	FOSL1 MMP9	1.03e-05	2	112	2	22461694
Pubmed	In silico cloning of mouse Muc5b gene and upregulation of its expression in mouse asthma model.	MUC5B MUC5AC	1.03e-05	2	112	2	11587997
Pubmed	Pathophysiological relevance of sputum MUC5AC and MUC5B levels in patients with mild asthma.	MUC5B MUC5AC	1.03e-05	2	112	2	34656442
Pubmed	Expression and clinical significance of ARTN and MMP-9 in endometrial carcinoma.	ARTN MMP9	1.03e-05	2	112	2	29254290
Pubmed	Regulation of high glucose-mediated mucin expression by matrix metalloproteinase-9 in human airway epithelial cells.	MMP9 MUC5AC	1.03e-05	2	112	2	25704757
Pubmed	Airway mucin MUC5AC and MUC5B concentrations and the initiation and progression of chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort.	MUC5B MUC5AC	1.03e-05	2	112	2	34058148
Pubmed	The structure and function of human IgA.	IGHA1 IGHA2	1.03e-05	2	112	2	2241915
Pubmed	Epstein-Barr virus latent membrane protein 2A promotes invasion of nasopharyngeal carcinoma cells through ERK/Fra-1-mediated induction of matrix metalloproteinase 9.	FOSL1 MMP9	1.03e-05	2	112	2	22514348
Pubmed	C-Mannosylation of MUC5AC and MUC5B Cys subdomains.	MUC5B MUC5AC	1.03e-05	2	112	2	14718370
Pubmed	Mucin production during prenatal and postnatal murine lung development.	MUC5B MUC5AC	1.03e-05	2	112	2	21653907
Pubmed	Mutations in a new gene encoding a protein of the hair bundle cause non-syndromic deafness at the DFNB16 locus.	STRC STRCP1	1.03e-05	2	112	2	11687802
Pubmed	Human mucin genes MUC2, MUC3, MUC4, MUC5AC, MUC5B, and MUC6 express stable and extremely large mRNAs and exhibit a variable length polymorphism. An improved method to analyze large mRNAs.	MUC5AC MUC6	1.03e-05	2	112	2	9422745
Pubmed	MUC5B mobilizes and MUC5AC spatially aligns mucociliary transport on human airway epithelium.	MUC5B MUC5AC	1.03e-05	2	112	2	36427316
Pubmed	Aberrant expression of MUC5AC and MUC6 gastric mucins and sialyl Tn antigen in intraepithelial neoplasms of the pancreas.	MUC5AC MUC6	1.03e-05	2	112	2	12360467
Pubmed	Metalloproteinases mediate mucin 5AC expression by epidermal growth factor receptor activation.	MMP9 MUC5AC	1.03e-05	2	112	2	15531749
Pubmed	Mucin deficiency causes functional and structural changes of the ocular surface.	MUC5B MUC5AC	1.03e-05	2	112	2	23272068
Pubmed	Younger patients with COME are more likely to have mucoid middle ear fluid containing mucin MUC5B.	MUC5B MUC5AC	1.03e-05	2	112	2	27729120
Pubmed	De novo NUF2 variant in a novel inherited bone marrow failure syndrome including microcephaly and renal hypoplasia.	MUC5B MUC5AC	1.03e-05	2	112	2	36111525
Pubmed	Foxn1 and Mmp-9 expression in intact skin and during excisional wound repair in young, adult, and old C57Bl/6 mice.	FOXN1 MMP9	1.03e-05	2	112	2	28371152
Pubmed	Normal murine respiratory tract has its mucus concentrated in clouds based on the Muc5b mucin.	MUC5B MUC5AC	1.03e-05	2	112	2	32348677
Pubmed	Reassessment of the importance of mucins in determining sputum properties in cystic fibrosis.	MUC5B MUC5AC	1.03e-05	2	112	2	24332705
Pubmed	Structure and function of immunoglobulins.	IGHA1 IGHA2 IGHG3	1.44e-05	15	112	3	20176268
Pubmed	Mammalian Otolin: a multimeric glycoprotein specific to the inner ear that interacts with otoconial matrix protein Otoconin-90 and Cerebellin-1.	STRC STRCP1 OTOG	2.14e-05	17	112	3	20856818
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	NCOA6 CARMIL2 MAPT ZCCHC14 NHSL1 FAM117A MEGF8 EIF4G1 ZNF598 WNK4 PPP1R12C OTOG	2.25e-05	861	112	12	36931259
Pubmed	Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux.	MUC5B MUC5AC MUC6	2.56e-05	18	112	3	18834073
Pubmed	Analysis of expansion of myeloid progenitors in mice to identify leukemic susceptibility genes.	APOH KLF13 NOTCH4	2.56e-05	18	112	3	16897342
Pubmed	Teashirt 1 (Tshz1) is essential for the development, survival and function of hypoglossal and phrenic motor neurons in mouse.	MAPT HOXA5 TSHZ1	3.03e-05	19	112	3	31427287
Pubmed	Tau interacts with SHP2 in neuronal systems and in Alzheimer's disease brains.	MAPT PTPN11	3.08e-05	3	112	2	31201283
Pubmed	Cochlear outer hair cell horizontal top connectors mediate mature stereocilia bundle mechanics.	STRC STRCP1	3.08e-05	3	112	2	30801007
Pubmed	Climbing fiber input shapes reciprocity of Purkinje cell firing.	MAPT ROBO3	3.08e-05	3	112	2	23643935
Pubmed	Expression of SHP2 and related markers in non-small cell lung cancer: a tissue microarray study of 80 cases.	PTPN11 MMP9	3.08e-05	3	112	2	23343958
Pubmed	High-Mobility Group Box 1 Upregulates MUC5AC and MUC5B Expression in Primary Airway Epithelial Cells.	MUC5B MUC5AC	3.08e-05	3	112	2	29286856
Pubmed	Scarless skin wound healing in FOXN1 deficient (nude) mice is associated with distinctive matrix metalloproteinase expression.	FOXN1 MMP9	3.08e-05	3	112	2	21539913
Pubmed	Fra-1 and Stat3 synergistically regulate activation of human MMP-9 gene.	FOSL1 MMP9	3.08e-05	3	112	2	17572495
Pubmed	Nebulized Menthol Impairs Mucociliary Clearance via TRPM8 and MUC5AC/MUC5B in Primary Airway Epithelial Cells.	MUC5B MUC5AC	3.08e-05	3	112	2	36675209
Pubmed	Th2 cytokines orchestrate the secretion of MUC5AC and MUC5B in IL-5-positive chronic rhinosinusitis with nasal polyps.	MUC5B MUC5AC	3.08e-05	3	112	2	29802623
Pubmed	Cadherin-catenin adhesion system and mucin expression: a comparison between young and older patients with gastric carcinoma.	MUC5AC MUC6	3.08e-05	3	112	2	18825309
Pubmed	Nuclear receptor coactivator 6 promotes HTR-8/SVneo cell invasion and migration by activating NF-κB-mediated MMP9 transcription.	NCOA6 MMP9	3.08e-05	3	112	2	32790097
Pubmed	Acrolein-activated matrix metalloproteinase 9 contributes to persistent mucin production.	MMP9 MUC5AC	3.08e-05	3	112	2	18006877
Pubmed	Adenomatous and foveolar gastric dysplasia: distinct patterns of mucin expression and background intestinal metaplasia.	MUC5AC MUC6	3.08e-05	3	112	2	18300795
Pubmed	A comprehensive analysis of common genetic variation in MUC1, MUC5AC, MUC6 genes and risk of stomach cancer.	MUC5AC MUC6	3.08e-05	3	112	2	19924550
Pubmed	Resistin upregulates MUC5AC/B mucin gene expression in human airway epithelial cells.	MUC5B MUC5AC	3.08e-05	3	112	2	29604272
Pubmed	Polycystin-1 activates the calcineurin/NFAT (nuclear factor of activated T-cells) signaling pathway.	NFATC1 PKD1	3.08e-05	3	112	2	15466861
Pubmed	Matrix metalloproteinase 9 (MMP-9) is upregulated during scarless wound healing in athymic nude mice.	FOXN1 MMP9	3.08e-05	3	112	2	17010584
Pubmed	Aquaporin 5 expression increases mucin production in lung adenocarcinoma.	MUC5B MUC5AC	3.08e-05	3	112	2	21455588
Pubmed	Expression of leptin receptor in nasal polyps: leptin as a mucosecretagogue.	MUC5B MUC5AC	3.08e-05	3	112	2	20422702
Pubmed	Mucin gene polymorphisms in otitis media patients.	MUC5B MUC5AC	3.08e-05	3	112	2	19718741
Pubmed	Interleukin-33 induces mucin gene expression and goblet cell hyperplasia in human nasal epithelial cells.	MUC5B MUC5AC	3.08e-05	3	112	2	27776277
Pubmed	Coactivator ASC-2 mediates heat shock factor 1-mediated transactivation dependent on heat shock.	NCOA6 HSF1	3.08e-05	3	112	2	14960326
Pubmed	Mucin expression in reactive gastropathy: an immunohistochemical analysis.	MUC5AC MUC6	3.08e-05	3	112	2	17227128
Pubmed	Mucin phenotype expression of gastric neuroendocrine neoplasms: analysis of histopathology and carcinogenesis.	MUC5AC MUC6	3.08e-05	3	112	2	23828549
Pubmed	CD147 increases mucus secretion induced by cigarette smoke in COPD.	MMP9 MUC5AC	3.08e-05	3	112	2	30727993
Pubmed	Autophagy of mucin granules contributes to resolution of airway mucous metaplasia.	MUC5B MUC5AC	3.08e-05	3	112	2	34158522
Pubmed	IL-8 regulates mucin gene expression at the posttranscriptional level in lung epithelial cells.	MUC5B MUC5AC	3.08e-05	3	112	2	19596978
Pubmed	Regulation of neuregulin 1beta1-induced MUC5AC and MUC5B expression in human airway epithelium.	MUC5B MUC5AC	3.08e-05	3	112	2	19556605
Pubmed	Transcriptome characterization elucidates signaling networks that control human ES cell growth and differentiation.	NPIPB12 MYO9B KIAA0586 SH3D21 ZCCHC14 TGIF1 PTPN11 ZC3H4 TONSL PKD1 MICAL3 ROBO3 MMP9 INO80B	3.71e-05	1215	112	14	15146197
Pubmed	E3 ubiquitin ligase FBXW7 balances airway cell fates.	TGIF1 MUC5AC NOTCH4	4.79e-05	22	112	3	34998785
Pubmed	Stereocilin-deficient mice reveal the origin of cochlear waveform distortions.	STRC STRCP1	6.14e-05	4	112	2	18849963
Pubmed	Neotenic phenomenon in gene expression in the skin of Foxn1- deficient (nude) mice - a projection for regenerative skin wound healing.	FOXN1 MMP9	6.14e-05	4	112	2	28068897
Pubmed	Characterization, quantification, and assessment of immune protection potential of secretory immunoglobulin A in colostrum samples from Saudi women.	IGHA1 IGHA2	6.14e-05	4	112	2	24145934
Pubmed	Increased expression of MUC5AC and MUC5B promoting bacterial biofilm formation in chronic rhinosinusitis patients.	MUC5B MUC5AC	6.14e-05	4	112	2	25638393
Pubmed	Expression of MUC1, MUC2, MUC5AC and MUC5B in mucinous lesions of the breast.	MUC5B MUC5AC	6.14e-05	4	112	2	22269464
Pubmed	Munc13-2-/- baseline secretion defect reveals source of oligomeric mucins in mouse airways.	MUC5B MUC5AC	6.14e-05	4	112	2	18258655
Interaction	TOP3B interactions	SEMA6C NCOA6 TBKBP1 MYO9B PPRC1 PEX6 C15orf39 SRCAP HES2 HIVEP3 ZCCHC14 NHSL1 MAP1S SLC16A5 MEGF8 ADAMTSL5 NFATC1 ADAMTS7 A4GALT EIF4G1 PKD1 LRP3 DISP2 MICAL3 ZNF598 BAHCC1	1.92e-08	1470	104	26	int:TOP3B
Interaction	GNG8 interactions	MUC5B APOH FCGBP IGHA1 IGHA2 IGHG3 MMP9 MUC5AC	2.74e-07	125	104	8	int:GNG8
Interaction	SPNS3 interactions	MUC5B SPNS3 IGHA1 IGHA2	3.74e-06	21	104	4	int:SPNS3
Interaction	HBM interactions	MUC5B IGHA1 IGHA2 MUC5AC	1.07e-05	27	104	4	int:HBM
Interaction	RIBC1 interactions	DISC1 IGHA1 IGHA2 MUC5AC KRT36	1.84e-05	63	104	5	int:RIBC1
GeneFamily	CD molecules\|Mucins	MUC5B MUC5AC MUC6	6.74e-05	21	69	3	648
ToppCell	Healthy_Control-Lymphoid-B-\|Healthy_Control / Condition, Lineage, Cell class and cell subclass	GRIN2C FAM117A IGHA1 IGHA2 IGHG3 NOTCH4	3.59e-06	163	112	6	d84bd41b4494c7d5c7f88d511bfe481fb12f079d
ToppCell	Healthy_Control-Lymphoid-B\|Healthy_Control / Condition, Lineage, Cell class and cell subclass	GRIN2C FAM117A IGHA1 IGHA2 IGHG3 NOTCH4	3.59e-06	163	112	6	0f723ec2503afa1b3ebb0754972438ffb6e6179d
ToppCell	COVID-19-lung-B_cells\|lung / Disease (COVID-19 only), tissue and cell type	PRDM2 IGHA1 IGHA2 IGHG3 MICAL3 RASGRP2	5.77e-06	177	112	6	f54691e5558091c1734ab15153a10bff15ed171e
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_B-Plasma_cell-B_c05-MZB1-XBP1\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	B4GALT2 NPIPB12 IGHA1 IGHA2 IGHG3 NPIPA2	5.96e-06	178	112	6	6765c6970b1f2b719a20d2afd7471e1c262f3fc4
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_B-Plasma_cell\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	B4GALT2 NPIPB12 IGHA1 IGHA2 IGHG3 NPIPA2	5.96e-06	178	112	6	693f1135d9c5545945e80c7ba3d098afc0ccac29
ToppCell	tumor_Lung-B_lymphocytes\|tumor_Lung / Location, Cell class and cell subclass	PRDM2 IGHA1 IGHA2 IGHG3 MICAL3 RASGRP2	7.66e-06	186	112	6	a54b368d7921185c583e35b532a6898c5486c2fc
ToppCell	P28-Endothelial-capillary_endothelial_cell-capillary_endothelial_cell_of_alveolus\|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	MAPT DGKZ FNDC1 IGFBP7 ADAMTSL5 RASGRP2	7.66e-06	186	112	6	375642f353842184792a834361284d6897c728de
ToppCell	5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SGIP1 INAFM1 HOXA5 FNDC1 IGFBP7 A4GALT	7.66e-06	186	112	6	f07e0c0d9c80ac9d8d679950e7d0c812becb85a3
ToppCell	facs-Lung-nan-3m-Endothelial-Capillary_Aerocyte_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SGIP1 DGKZ FNDC1 IGFBP7 ADAMTSL5 A4GALT	8.39e-06	189	112	6	09dd2b3d89416192e84abe302a6237b8f3fdcb6e
ToppCell	Enterocyte_Progenitors-C_06\|Enterocyte_Progenitors / shred on cell type and cluster	MUC5B FCGBP IGHA1 IGHG3 MUC5AC MUC6	9.18e-06	192	112	6	b9938e1a929c00628cc6ebfdf10cf285167f445c
ToppCell	C_06\|World / shred on cell type and cluster	MUC5B CD320 IGHA1 IGHG3 MUC5AC MUC6	9.74e-06	194	112	6	5cb42e09f380c4468cdc603ec0c3de35eadd3213
ToppCell	LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	SGIP1 MAPT WFDC1 ARHGEF25 IGFBP7 CCN3	1.16e-05	200	112	6	b5b5a32925f225610fe25a021a742d6397162863
ToppCell	Frontal_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Synpr-Inhibitory_Neuron.Gad1Gad2-Slc17a8.Synpr-Sncg-Yjefn3_(Neuron.Gad1Gad2-Slc17a8.Synpr-Sncg-Yjefn3)-\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	HES2 FCGBP GRID2IP KRT36	2.47e-05	67	112	4	e53dfc288c943656a0b064afe593ea2101d75437
ToppCell	Frontal_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Synpr-Inhibitory_Neuron.Gad1Gad2-Slc17a8.Synpr-Sncg-Yjefn3_(Neuron.Gad1Gad2-Slc17a8.Synpr-Sncg-Yjefn3)\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	HES2 FCGBP GRID2IP KRT36	2.47e-05	67	112	4	1841cee311a4b1b802c9e872793435afb730592f
ToppCell	Smart-seq2-tissue-resident_(Smart-seq2)-lymphocytic-T_lymphocytic-CD4-positive,_alpha-beta_memory_T_cell\|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	GPR137 NID2 DGKZ ZNF831 GPRIN1	2.69e-05	139	112	5	7c02caed5b9baf233bd6fb9a453708b3e157c790
ToppCell	E16.5-samps-Mesenchymal-Myofibroblast-Migrating_MyoFibroblast\|E16.5-samps / Age Group, Lineage, Cell class and subclass	SGIP1 ZNF831 FNDC1 TSHZ1 ROBO3	4.53e-05	155	112	5	1882fa5fd25f77d6e3ac47b613f6fb3c67d8e50c
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Myocytic\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SGIP1 MAPT WFDC1 ARTN IGFBP7	4.68e-05	156	112	5	6365b69ede98bc866e996bc52736b00401aacf6f
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_B-Plasma_cell\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	B4GALT2 IGHA1 IGHA2 IGHG3 NPIPA2	5.59e-05	162	112	5	8278dccdb139396ede34b83b02ebce837f2489d6
ToppCell	Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	WFDC1 ARTN IGFBP7 ADAMTSL5 STRC	5.76e-05	163	112	5	51dee6c21cbeca4e17d1cc386e203f0c403089e8
ToppCell	343B-Lymphocytic-Plasma_cell\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	SH3D21 IGHA1 IGHA2 IGHG3 OCSTAMP	5.93e-05	164	112	5	cf62d34ce9dd220fe61748466c84fd70d9ba697c
ToppCell	343B-Lymphocytic-Plasma_cell-\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	SH3D21 IGHA1 IGHA2 IGHG3 OCSTAMP	5.93e-05	164	112	5	e00549bc8b3a5566f39031f39d7e698b0b107a7f
ToppCell	5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TBKBP1 MUC5B FCGBP MUC5AC BAHCC1	6.28e-05	166	112	5	60060b03f2abfa3cc08107ab5a9f578e60e4ae16
ToppCell	5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TBKBP1 MUC5B FCGBP MUC5AC BAHCC1	6.28e-05	166	112	5	ec9161d388db5a257b8d125c14f9dd911d5d5d4a
ToppCell	356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6\|356C / Donor, Lineage, Cell class and subclass (all cells)	ZNF831 CDAN1 ZC3H4 SIMC1 NOTCH4	6.28e-05	166	112	5	c4f7ea1cad962b1d6ad77423d15978b68a0d6f1d
ToppCell	5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)-\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TBKBP1 MUC5B FCGBP MUC5AC BAHCC1	6.28e-05	166	112	5	4586d6725403f879fc96f67be579022587ce1906
ToppCell	wk_20-22-Hematologic-Myeloid-GMP\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	ARTN SPNS3 RREB1 SH3D21 ZNF598	6.28e-05	166	112	5	d96e88e73a40205f32cebd7e54ca1ff09ee1e7e8
ToppCell	Adult-Epithelial-lung_goblet_cell-D122\|Adult / Lineage, Cell type, age group and donor	C19orf67 MUC5B FCGBP STRC MUC5AC	6.46e-05	167	112	5	6efbb2ef6adc8da5dd67210969f825f5cc8ed022
ToppCell	367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0\|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells)	SEMA6C SRCAP HES2 MAP1S MEGF8	6.65e-05	168	112	5	2fb2d916eb5000a637240d38e47a9b4f61f9f83f
ToppCell	ASK440-Immune-B_cell\|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq	B4GALT2 CD320 IGHA1 IGHA2 IGHG3	6.65e-05	168	112	5	127559d1a083c68cda9fce143afcc3eec168df17
ToppCell	BAL-Control-Lymphocyte-B-Plasmablast\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	CD320 FAM117A IGHA1 IGHA2 IGHG3	6.83e-05	169	112	5	9ab34f602d46ce87283d243b81621e8806504f43
ToppCell	BAL-Control-Lymphocyte-B-Plasmablast-Plasmablast\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	CD320 FAM117A IGHA1 IGHA2 IGHG3	6.83e-05	169	112	5	89fbafdb4628ce7a90c50398870e0f8ee90cfd91
ToppCell	BAL-Control-Lymphocyte-B-Plasmablast-Plasmablast-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	CD320 FAM117A IGHA1 IGHA2 IGHG3	6.83e-05	169	112	5	75d367eb35768d3063096e8866cea649dac3b1bd
ToppCell	BAL-Control-Lymphocyte-B-Plasmablast-Plasmablast-Plasmablast\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CD320 FAM117A IGHA1 IGHA2 IGHG3	7.03e-05	170	112	5	7dcb6319ba4d7b258dd0a17449d837800ef46ccc
ToppCell	BAL-Control-Lymphocyte-B-Plasmablast-Plasmablast\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CD320 FAM117A IGHA1 IGHA2 IGHG3	7.03e-05	170	112	5	7377e59fba4bf97ba893ccf6b5e149b5152407be
ToppCell	E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP-PMP_prolif\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TGIF1 MAP1S SIMC1 LRP3 MAST3	7.03e-05	170	112	5	b1a16600754e0c12f7d39c9221f1b03135833f16
ToppCell	BAL-Control-Lymphocyte-B-Plasmablast\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CD320 FAM117A IGHA1 IGHA2 IGHG3	7.03e-05	170	112	5	e18211029e9ffad54458fd921f455172aad407c7
ToppCell	Bronchial_Brush-Immune-B_cells\|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X	CD320 IGHA1 KLF13 IGHA2 IGHG3	7.03e-05	170	112	5	53e9372cb06a2dc5c8ecb3f9af42f3c23da96431
ToppCell	5'-Adult-LargeIntestine-Epithelial-goblet-Goblet_cell\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MUC5B HES2 FCGBP DISP2 WNK4	7.23e-05	171	112	5	48125d825ca2d7ef34564250f5b47d2a579e03c9
ToppCell	5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-Pericytes-angiogenic_pericyte\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TTYH1 ARTN GRIN2C IGFBP7 RASGRP2	7.23e-05	171	112	5	285533ca2a6a411773313166bee35542f34d1a3c
ToppCell	Control-B_cell-Plasmablast\|Control / Disease group,lineage and cell class （2021.01.30）	CD320 FAM117A IGHA1 IGHA2 IGHG3	7.23e-05	171	112	5	c09afc4b111b2b5acca75177554f6364ee02d37c
ToppCell	343B-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	SPNS3 MICAL2 DISP2 MUC5AC CCDC157	7.43e-05	172	112	5	d65ffff3e341af34a043a0d802d7ba4b69de36e9
ToppCell	Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	WFDC1 ARHGEF25 IGFBP7 MICAL3 MUC5AC	7.63e-05	173	112	5	5416b092321c7d9b63f0418c60f2402a138355bf
ToppCell	droplet-Lung-30m-Hematologic-myeloid-Basophil/Mast_cell-basophil_l26\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	C15orf39 SPNS3 ARHGEF25 FOSL1 IGFBP7	7.84e-05	174	112	5	009e88a6c79689a5d88b0af50aa89aa03b33f800
ToppCell	Multiple_Sclerosis-Lymphocyte-B-Plasmablast\|Multiple_Sclerosis / Disease, Lineage and Cell Type	B4GALT2 NPIPA8 IGHA1 IGHA2 IGHG3	7.84e-05	174	112	5	e8d2aa9505817aac3fe068080774d19458f07b01
ToppCell	wk_15-18-Epithelial-Proximal_epithelial-SMG_basal_1\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	TTYH1 FOXN1 MUC5B FOSL1 FCGBP	7.84e-05	174	112	5	aceca0a22bb1e380835e792681cfc9b752fb5496
ToppCell	droplet-Lung-immune-endo-depleted-3m-Myeloid-Myeloid_Dendritic_Type_2\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPNS3 FAM117A CCDC157 MAST3 OCSTAMP	8.06e-05	175	112	5	bb058e714d21a0ec8532eaf3c7dd2faf78016bc0
ToppCell	356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6\|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells)	ZNF831 CDAN1 ZC3H4 SIMC1 NOTCH4	8.06e-05	175	112	5	f3a68aeb79c4935006e17a5ff3445a8ec0e33f5f
ToppCell	severe-B_memory\|World / disease stage, cell group and cell class	PRDM2 IGHA1 IGHA2 MICAL3 FHDC1	8.28e-05	176	112	5	4e5c6b1aa5ffd13593a6bcd1e1253c1737c5c2b4
ToppCell	droplet-Liver-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAPT KIAA0586 ARHGEF25 IGFBP7 DISP2	8.50e-05	177	112	5	8ef41ee5d63737b810ad7371b0437625e7e1badf
ToppCell	390C-Lymphocytic-B_cell-\|390C / Donor, Lineage, Cell class and subclass (all cells)	PRDM2 NFATC1 IGHA1 IGHA2 IGHG3	8.73e-05	178	112	5	02cb514096435a4d8c84f0cc12ae627db319621d
ToppCell	390C-Lymphocytic-B_cell\|390C / Donor, Lineage, Cell class and subclass (all cells)	PRDM2 NFATC1 IGHA1 IGHA2 IGHG3	8.73e-05	178	112	5	9af29e341087ba4dd3ef246cdbae6469ea9de15f
ToppCell	FF-Differ-KC\|World / shred by cell class for mouse tongue	FOXN1 HES2 NHSL1 A4GALT KRT36	8.96e-05	179	112	5	1526a130565a97c291a25a7a988089bffc1515c1
ToppCell	IPF-Lymphoid-B\|World / Disease state, Lineage and Cell class	PRDM2 IGHA1 IGHA2 IGHG3 MICAL3	9.20e-05	180	112	5	30f9398c9b784f49470847a025bac90687e997a1
ToppCell	tumor_Lymph_Node_/_Brain-B_lymphocytes-Plasma_cells\|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass	WFDC1 IGHA1 IGHA2 IGHG3	9.34e-05	94	112	4	4b6623de5a517ebf5df865e0dcd615111622ad3e
ToppCell	Control-Lymphoid-B\|World / Disease state, Lineage and Cell class	PRDM2 IGHA1 IGHA2 IGHG3 MICAL3	9.44e-05	181	112	5	9124f1a610cfc3355ad87921cd3eb5346956475d
ToppCell	metastatic_Lymph_Node-B_lymphocytes-Plasma_cells\|B_lymphocytes / Location, Cell class and cell subclass	IGHA1 IGHA2 IGHG3 MUC6 BAHCC1	9.69e-05	182	112	5	27d1688fdfc570cedd233aa7030bce7d9b604d42
ToppCell	IPF-Lymphoid-B\|IPF / Disease state, Lineage and Cell class	PRDM2 IGHA1 IGHA2 IGHG3 MICAL3	9.94e-05	183	112	5	e37d2c015c34471a8a54a0299e94b0371e1ada5a
ToppCell	3'-GW_trimst-2-LargeIntestine-Hematopoietic-T_cells-Treg\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CARMIL2 ZNF831 HIVEP3 MMP9 NPIPA2	9.94e-05	183	112	5	450c30d2e389fcb17825394c27f9ccc4f33022e3
ToppCell	nucseq-Immune-Lymphocytic_B\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	PRDM2 IGHA1 IGHA2 IGHG3 MICAL3	1.02e-04	184	112	5	911658e7bb499c1bbc8419eec8ff88729bc39a75
ToppCell	3'-GW_trimst-2-LargeIntestine-Epithelial-goblet-Goblet_cell\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FOXN1 MUC5B HES2 FCGBP WNK4	1.02e-04	184	112	5	886d2d9bf2fe31207f17e3edc309ef44029924e1
ToppCell	3'-GW_trimst-2-LargeIntestine-Epithelial-goblet\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FOXN1 MUC5B HES2 FCGBP WNK4	1.02e-04	184	112	5	936b39377eebea3961d702532779f6cd27953be7
ToppCell	Control-Lymphoid-B\|Control / Disease state, Lineage and Cell class	PRDM2 IGHA1 IGHA2 IGHG3 MICAL3	1.02e-04	184	112	5	de0294f879268bfd68e91adcc2adba211d221b7a
ToppCell	nucseq-Immune-Lymphocytic_B-Lymphocytic_B\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	PRDM2 IGHA1 IGHA2 IGHG3 MICAL3	1.02e-04	184	112	5	942b58ae7172bb5f97e55b032db9329d161854af
ToppCell	metastatic_Brain-Endothelial_cells-Stalk-like_ECs\|metastatic_Brain / Location, Cell class and cell subclass	SRCAP A4GALT DISP2 ROBO3 NOTCH4	1.05e-04	185	112	5	ad52970e88e8947ef256095bd4b40229b912d58a
ToppCell	droplet-Liver-LIVER_HEP-30m-Mesenchymal\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAPT WFDC1 ARHGEF25 ADAMTSL5 DISP2	1.05e-04	185	112	5	f814ec9d4ade717a0109398e9768d0d66f09317b
ToppCell	droplet-Liver-LIVER_HEP-30m-Mesenchymal-hepatic_stellate_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAPT WFDC1 ARHGEF25 ADAMTSL5 DISP2	1.05e-04	185	112	5	40e958511790e84321da5ccf735f9974c06a0263
ToppCell	droplet-Liver-LIVER_HEP-30m-Mesenchymal-hepatic_stellate_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAPT WFDC1 ARHGEF25 ADAMTSL5 DISP2	1.05e-04	185	112	5	5f2eeba80aff145e85cfd81e2890a155406badb9
ToppCell	Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	MYO9B FOSL1 IGFBP7 NFATC1 MICAL2	1.05e-04	185	112	5	e58a009aaf342be019a909747b1895d5987d4daf
ToppCell	metastatic_Brain-B_lymphocytes\|metastatic_Brain / Location, Cell class and cell subclass	IGHA1 KLF13 IGHA2 IGHG3 RASGRP2	1.05e-04	185	112	5	153b82dc5ace03f84dc82d724d56bdc93aa020df
ToppCell	COVID-19-lung-B_cells\|COVID-19 / Disease (COVID-19 only), tissue and cell type	PRDM2 IGHA1 IGHA2 IGHG3 RASGRP2	1.05e-04	185	112	5	e8f1ad580f19705b5ca1d7d8867b2125f4891684
ToppCell	COPD-Lymphoid-B\|World / Disease state, Lineage and Cell class	PRDM2 IGHA1 IGHA2 IGHG3 MICAL3	1.05e-04	185	112	5	22891ed75e25ef30dfa541cb82d85e08ce07e7d9
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c03-CD27-AIM2\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	TTLL5 IGHA1 IGHA2 SIMC1 MICAL3	1.07e-04	186	112	5	55b239834b96b1f7787ec77a7d19796d617bbbf0
ToppCell	nucseq-Mesenchymal-Myocytic-Myocytic_2-VSMC\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	WFDC1 ARTN ARHGEF25 IGFBP7 CCN3	1.07e-04	186	112	5	c7885fd6dc7dc8fffc96f0112c51a365cf8a8f80
ToppCell	3'-GW_trimst-1-LargeIntestine-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TTYH1 ARTN IGFBP7 A4GALT RASGRP2	1.10e-04	187	112	5	d52f7bc0afcdc366b20d199ab33c4ec60ed22a68
ToppCell	Healthy_donor-B_memory\|World / disease group, cell group and cell class (v2)	PRDM2 IGHA1 IGHA2 IGHG3 MICAL3	1.10e-04	187	112	5	4f68e3243071a4549c80aff8bff32c6ad892ee7f
ToppCell	Control-Lymphoid-B\|Lymphoid / Disease state, Lineage and Cell class	PRDM2 IGHA1 IGHA2 IGHG3 MICAL3	1.10e-04	187	112	5	4e64be635f445276e71f2937f33f041c3a4204ab
ToppCell	COVID-19_Severe-B_memory\|World / disease group, cell group and cell class	PRDM2 IGHA1 IGHA2 IGHG3 MICAL3	1.10e-04	187	112	5	f29c71f2505bb64f3010ada491d422b87a6f7db3
ToppCell	Frontal_cortex-Endothelial\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	NID2 WFDC1 SH3D21 IGFBP7 A4GALT	1.13e-04	188	112	5	a43392dbd10fc7dbfb31be39b8af8a7ea121c894
ToppCell	11.5-Airway-Mesenchymal-Pericyte\|Airway / Age, Tissue, Lineage and Cell class	MAPT WFDC1 ARTN IGFBP7 RASGRP2	1.13e-04	188	112	5	916971d8660fd20f616346953874e89d2cd13e88
ToppCell	390C-Lymphocytic-B_cell-\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	PRDM2 NFATC1 IGHA1 IGHA2 IGHG3	1.19e-04	190	112	5	f63c9474f23bb72f0bb1fc531342f0da04ed8b3e
ToppCell	5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TTYH1 ARTN IGFBP7 A4GALT RASGRP2	1.19e-04	190	112	5	a7f6c38bbf451f166febb21e6719d4afced4035e
ToppCell	human_hepatoblastoma-Endothelial_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	NID2 SGIP1 HIVEP3 NFATC1 NOTCH4	1.19e-04	190	112	5	8d6ef93d69e96cd6921816d152bea3b0710cf147
ToppCell	390C-Lymphocytic-B_cell\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	PRDM2 NFATC1 IGHA1 IGHA2 IGHG3	1.19e-04	190	112	5	53bf211f0e8a44f5adb89c43b210a1e35120b6a8
ToppCell	PBMC-Mild-Lymphocyte-B-B_cell-B_memory-B_memory-0\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	PRDM2 IGHA1 IGHA2 IGHG3 MICAL3	1.19e-04	190	112	5	95b9334573eefb132daaa9371377ad60232006ae
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell-B_c03-CD27-AIM2\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	PRDM2 IGHA1 IGHA2 IGHG3 MICAL3	1.19e-04	190	112	5	0db545a4cba7534bad2693e0d565cde7dbc7a586
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-Plasma_cell-B_c05-MZB1-XBP1\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	CD320 IGHA1 IGHA2 IGHG3 NPIPA2	1.19e-04	190	112	5	f85cdd79eefd699ada7a91bf4997cc730a9b9846
ToppCell	Tracheal-10x3prime_v2-Immune_Lymphocytic-B-B_plasma-B_plasma_IgA\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	IGHA1 KLF13 IGHA2 IGHG3 DISP2	1.22e-04	191	112	5	da4062a0f6d0af6d330acf11da216c64b0fa7c73
ToppCell	facs-Lung-Endomucin_-18m-Endothelial-Capillary_Aerocyte_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAPT IGFBP7 ADAMTSL5 A4GALT RASGRP2	1.22e-04	191	112	5	df8cdbc26443e55a203cbafa21b0952a2a55b9bf
ToppCell	3'-GW_trimst-1-SmallIntestine-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TTYH1 ARTN IGFBP7 A4GALT RASGRP2	1.22e-04	191	112	5	239c1e68eb1cbe3e137a99fbd6eeb8d64c919ffd
ToppCell	PBMC-Mild-Lymphocyte-B-B_cell-B_memory\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	PRDM2 IGHA1 IGHA2 IGHG3 MICAL3	1.22e-04	191	112	5	22134a2c1a92208bc1629a620ce73a56502613c2
ToppCell	facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_aerocyte_endothelial_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MAPT IGFBP7 ADAMTSL5 A4GALT RASGRP2	1.22e-04	191	112	5	40e617d3c93f03ae87baf6c0b2304b617f5fe782
ToppCell	COVID-19_Severe-B_intermediate\|World / disease group, cell group and cell class	PRDM2 IGHA1 IGHA2 IGHG3 MICAL3	1.22e-04	191	112	5	f226fd69a26124ba98e4544f550b89a08e6a3708
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-Plasma_cell\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	CD320 IGHA1 IGHA2 IGHG3 NPIPA2	1.25e-04	192	112	5	ec279980602292fc8ed6362edd36a5c772d59777
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive\|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	PPRC1 FOSL1 NFATC1 MICAL2 PIK3R5	1.25e-04	192	112	5	8b86db2ebe0199fee0e9800566a619a24bfdeed5
ToppCell	PBMC-Mild-Lymphocyte-B-B_cell-B_memory-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	PRDM2 IGHA1 IGHA2 IGHG3 MICAL3	1.25e-04	192	112	5	debd471f61cf3606b8e9c246add0be5df601af7f
ToppCell	5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-Pericytes\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TTYH1 ARTN IGFBP7 A4GALT RASGRP2	1.25e-04	192	112	5	71863f18a82394ed9f8e5ec8a4017215382a8284
ToppCell	COVID-19_Mild-Lymphoid_B-B_memory\|COVID-19_Mild / Disease group, lineage and cell class	PRDM2 IGHA1 IGHA2 IGHG3 MICAL3	1.25e-04	192	112	5	d27db7669de95bddbea8ccb83e6f10ae7240b1ab
ToppCell	PBMC-Mild-Lymphocyte-B-B_cell-B_memory\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	PRDM2 IGHA1 IGHA2 IGHG3 MICAL3	1.25e-04	192	112	5	314f74dd3c6d94839eed05b9a1a398217ef78029
ToppCell	10x_3'_v2v3-Non-neoplastic-Lymphoid-NK-NK-F\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ZNF831 CDAN1 FAM117A INO80B NOTCH4	1.25e-04	192	112	5	6d7dd35869d86c3e991a61e17825053a3bfab44d
ToppCell	mild_COVID-19-B_memory\|World / disease group, cell group and cell class (v2)	PRDM2 IGHA1 IGHA2 IGHG3 MICAL3	1.28e-04	193	112	5	69b70c838328fdc7dbb6b5449fe2811a5389a839
Drug	Medrysone [2668-66-8]; Up 200; 11.6uM; MCF7; HT_HG-U133A	GPR137 MAPT DISC1 MUC5B APOH IGFBP7 ADAMTS7 ZNF358 A4GALT MUC6	2.41e-08	197	104	10	4727_UP
Drug	Midodrine hydrochloride [3092-17-9]; Up 200; 13.8uM; PC3; HT_HG-U133A	GPR137 MYO9B TTLL5 HES2 USP20 HIVEP3 MAP1S KLF13 LRP3 INO80B	2.78e-08	200	104	10	7156_UP
Drug	Ethisterone [434-03-7]; Up 200; 12.8uM; MCF7; HT_HG-U133A	TBKBP1 TTLL5 ARTN SH3D21 NFATC1 MICAL2 MUC6 INO80B CCN3	3.20e-07	198	104	9	3975_UP
Drug	Methylhydantoin-5-(L) [40856-73-3]; Up 200; 35uM; MCF7; HT_HG-U133A	SH3D21 A4GALT QSER1 ROBO3 HSF1 MUC5AC PIK3R5 CCN3	3.20e-06	195	104	8	3378_UP
Drug	Spectinomycin dihydrochloride [21736-83-4]; Down 200; 9.8uM; MCF7; HT_HG-U133A	MYO9B TTLL5 KIAA0586 SRCAP MAP1S ZNF358 MAST3 BAHCC1	3.32e-06	196	104	8	3327_DN
Drug	Triamterene [396-01-0]; Down 200; 15.8uM; PC3; HT_HG-U133A	B4GALT2 GPR137 PRR36 PPRC1 SRCAP LRP3 ROBO3 CCN3	3.32e-06	196	104	8	1819_DN
Drug	Oxybenzone [131-57-7]; Down 200; 17.6uM; PC3; HT_HG-U133A	NID2 MAPT MYO9B TTLL5 PEX6 SRCAP HES2 LRP3	3.32e-06	196	104	8	6309_DN
Drug	Protoveratrine A [143-57-7]; Up 200; 5uM; MCF7; HT_HG-U133A	ARTN SRCAP SH3D21 PRDM2 ZCCHC14 MEGF8 INO80B BAHCC1	3.32e-06	196	104	8	2800_UP
Drug	Fosfosal [6064-83-1]; Down 200; 18.4uM; MCF7; HT_HG-U133A	GPR137 ARTN SRCAP FOSL1 ZNF358 LRP3 MUC5AC BAHCC1	3.45e-06	197	104	8	3336_DN
Drug	Trichlormethiazide [133-67-5]; Down 200; 10.6uM; MCF7; HT_HG-U133A	GPR137 PRR36 MYO9B DISC1 TTLL5 ARTN HIVEP3 ZCCHC14	3.45e-06	197	104	8	3337_DN
Drug	Betazole hydrochloride; Up 200; 27uM; MCF7; HT_HG-U133A	GPR137 DISC1 TTLL5 ARTN SRCAP USP20 LRP3 INO80B	3.58e-06	198	104	8	1690_UP
Drug	Letrozole [112809-51-5]; Down 200; 14uM; MCF7; HT_HG-U133A	PRR36 TTLL5 ARTN HIVEP3 KLF13 A4GALT ROBO3 INO80B	3.86e-06	200	104	8	4824_DN
Drug	Camptothecine (S,+) [7689-03-4]; Up 200; 11.4uM; MCF7; HT_HG-U133A	MUC5B HES2 SH3D21 FOSL1 HOXA5 ADAMTS7 MUC5AC	2.05e-05	182	104	7	2321_UP
Drug	paeony root	APOH FOSL1 TONSL HSF1	2.16e-05	36	104	4	CID000073358
Drug	17-AAG; Down 200; 1uM; HL60; HT_HG-U133A	SRCAP FOSL1 HIVEP3 MEGF8 LRP3 INO80B RASGRP2	2.90e-05	192	104	7	6185_DN
Drug	0317956-0000 [391210-11-0]; Down 200; 1uM; MCF7; HT_HG-U133A	PRR36 MYO9B TTLL5 MUC5B SRCAP FOSL1 RASGRP2	3.10e-05	194	104	7	3969_DN
Drug	Fusaric acid [536-69-6]; Up 200; 22.4uM; MCF7; HT_HG-U133A	GPR137 PRR36 DISC1 C15orf39 ARTN HIVEP3 BAHCC1	3.10e-05	194	104	7	3245_UP
Drug	Fillalbin [4540-25-4]; Up 200; 13.8uM; PC3; HT_HG-U133A	ARTN SRCAP SLC16A5 MICAL2 INO80B MAST3 RASGRP2	3.10e-05	194	104	7	4092_UP
Drug	Dicumarol [66-76-2]; Down 200; 11.8uM; MCF7; HT_HG-U133A	GPR137 PRR36 MUC5B ARTN SRCAP HIVEP3 RASGRP2	3.20e-05	195	104	7	3941_DN
Drug	(-)-Eseroline fumarate salt [104015-29-4]; Down 200; 12uM; MCF7; HT_HG-U133A	MAPT MYO9B USP20 ZCCHC14 MICAL3 ROBO3 INO80B	3.20e-05	195	104	7	3530_DN
Drug	5194442; Up 200; 20uM; MCF7; HT_HG-U133A	GPR137 TTLL5 ARTN FOSL1 ZCCHC14 MAP1S MEGF8	3.20e-05	195	104	7	6558_UP
Drug	Sulindac [38194-50-2]; Down 200; 11.2uM; PC3; HT_HG-U133A	MAPT PEX6 HES2 NFATC1 QSER1 INO80B MAST3	3.20e-05	195	104	7	5103_DN
Drug	PNU-0230031 [267429-39-0]; Up 200; 10uM; PC3; HT_HG-U133A	PRR36 MYO9B SLC16A5 ADAMTS7 MICAL2 MUC5AC RASGRP2	3.30e-05	196	104	7	4288_UP
Drug	Thiamine hydrochloride [67-03-8]; Up 200; 11.8uM; MCF7; HT_HG-U133A	GPR137 DISC1 ARTN SRCAP USP20 PRDM2 MAST3	3.30e-05	196	104	7	7479_UP
Drug	Foliosidine [2520-38-9]; Down 200; 13uM; PC3; HT_HG-U133A	MAPT TTLL5 USP20 KLF13 ZNF358 LRP3 BAHCC1	3.41e-05	197	104	7	4295_DN
Drug	Androsterone [53-41-8]; Up 200; 13.8uM; PC3; HT_HG-U133A	TTLL5 ARTN APOH HES2 SH3D21 ZNF358 MMP9	3.41e-05	197	104	7	4635_UP
Drug	Ethamivan [304-84-7]; Up 200; 18uM; PC3; HT_HG-U133A	TBKBP1 MYO9B PPRC1 USP20 HIVEP3 LRP3 HSF1	3.41e-05	197	104	7	7260_UP
Drug	Josamycin [16846-24-5]; Up 200; 4.8uM; PC3; HT_HG-U133A	TTYH1 ARTN APOH MICAL2 ZNF358 MUC6 RASGRP2	3.41e-05	197	104	7	4631_UP
Drug	Chlorogenic acid [327-97-9]; Down 200; 11.2uM; MCF7; HT_HG-U133A	GPR137 DISC1 TTLL5 HIVEP3 ZCCHC14 KLF13 BAHCC1	3.41e-05	197	104	7	4142_DN
Drug	Furosemide [54-31-9]; Down 200; 12uM; PC3; HT_HG-U133A	GPR137 NID2 MUC5B ARTN USP20 MICAL3 HSF1	3.41e-05	197	104	7	4503_DN
Drug	Netilmicin sulfate [56931-57-2]; Up 200; 2.8uM; MCF7; HT_HG-U133A	GPR137 TBKBP1 ARTN ADAMTS7 ZNF358 INO80B RASGRP2	3.41e-05	197	104	7	3524_UP
Drug	Benfluorex hydrochloride [23642-66-2]; Up 200; 10.4uM; HL60; HT_HG-U133A	B4GALT2 TBKBP1 PEX6 SRCAP USP20 MMP9 RASGRP2	3.53e-05	198	104	7	1266_UP
Drug	Suprofen [40828-46-4]; Down 200; 15.4uM; PC3; HT_HG-U133A	DISC1 ARTN SH3D21 HIVEP3 QSER1 INO80B MAST3	3.53e-05	198	104	7	4005_DN
Drug	Deltaline [6836-11-9]; Up 200; 7.8uM; MCF7; HT_HG-U133A	ARTN SRCAP HIVEP3 ADAMTS7 A4GALT PIK3R5 RASGRP2	3.53e-05	198	104	7	3831_UP
Drug	Methyldopa (L,-) [555-30-6]; Up 200; 19uM; MCF7; HT_HG-U133A	TBKBP1 SRCAP SH3D21 ZCCHC14 SLC16A5 MEGF8 RASGRP2	3.53e-05	198	104	7	5272_UP
Drug	Canrenoic acid potassium salt [2181-04-6]; Up 200; 10uM; PC3; HT_HG-U133A	GPR137 TTYH1 PRR36 C15orf39 ARTN SRCAP CCN3	3.53e-05	198	104	7	2065_UP
Drug	aspirin, USP; Up 200; 100uM; PC3; HT_HG-U133A	TBKBP1 DISC1 ARTN SRCAP MEGF8 KLF13 RASGRP2	3.53e-05	198	104	7	4428_UP
Drug	Methoxamine hydrochloride [61-16-5]; Up 200; 16.2uM; PC3; HT_HG-U133A	NID2 TBKBP1 MAPT TTLL5 SH3D21 ZCCHC14 A4GALT	3.53e-05	198	104	7	6627_UP
Drug	Piretanide [55837-27-9]; Up 200; 11uM; MCF7; HT_HG-U133A	MYO9B ARTN HIVEP3 SLC16A5 KLF13 QSER1 RASGRP2	3.64e-05	199	104	7	6828_UP
Drug	Calciferol [50-14-6]; Down 200; 10uM; HL60; HT_HG-U133A	TTLL5 SRCAP HIVEP3 MAP1S MEGF8 INO80B RASGRP2	3.64e-05	199	104	7	2442_DN
Drug	Verapamyl hydrochloride [152-11-4]; Up 200; 8.2uM; PC3; HT_HG-U133A	MAPT MUC5B ARTN ZCCHC14 MUC5AC INO80B BAHCC1	3.64e-05	199	104	7	6287_UP
Drug	Doxazosin mesylate [77883-43-3]; Up 200; 7.4uM; MCF7; HT_HG-U133A	PRR36 MYO9B TTLL5 HES2 ZCCHC14 ZNF358 ROBO3	3.64e-05	199	104	7	4988_UP
Drug	Diphenylpyraline hydrochloride [132-18-3]; Up 200; 12.6uM; MCF7; HT_HG-U133A	PRR36 TTLL5 PRDM2 NFATC1 KLF13 HSF1 RASGRP2	3.64e-05	199	104	7	3640_UP
Drug	valdecoxib; Down 200; 10uM; MCF7; HT_HG-U133A	GPR137 TTLL5 SRCAP SLC16A5 ZNF358 ROBO3 MUC5AC	3.64e-05	199	104	7	6403_DN
Drug	Dipyrone [5907-38-0]; Up 200; 12uM; MCF7; HT_HG-U133A	MUC5B ARTN SH3D21 HIVEP3 NFATC1 PIK3R5 RASGRP2	3.64e-05	199	104	7	3835_UP
Drug	Phenethicillin potassium salt [132-93-4]; Up 200; 10uM; MCF7; HT_HG-U133A	GPR137 TBKBP1 MUC5B SRCAP HIVEP3 ADAMTS7 MUC6	3.64e-05	199	104	7	6105_UP
Drug	Iohexol [66108-95-0]; Up 200; 4.8uM; MCF7; HT_HG-U133A	GPR137 PRR36 ARTN HES2 SH3D21 ZCCHC14 ROBO3	3.76e-05	200	104	7	3322_UP
Drug	leucocrystal violet	TTLL5 APOH	1.23e-04	4	104	2	CID000069048
Drug	Miconazole [22916-47-8]; Up 200; 9.6uM; MCF7; HT_HG-U133A	MYO9B ARTN SRCAP PRDM2 FOSL1 BAHCC1	1.80e-04	180	104	6	1477_UP
Drug	AC1NRNSN	NCOA6 HIVEP3 IGFBP7 TSHZ1	1.99e-04	63	104	4	CID005244174
Drug	17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A	GPR137 MYO9B C15orf39 MMP9 INO80B BAHCC1	2.08e-04	185	104	6	5585_DN
Drug	prochlorperazine dimaleate salt; Up 200; 10uM; MCF7; HT_HG-U133A	MAPT TTLL5 SRCAP HES2 A4GALT INO80B	2.21e-04	187	104	6	6975_UP
Drug	Mebendazole [31431-39-7]; Up 200; 13.6uM; MCF7; HT_HG-U133A	SRCAP FOSL1 ADAMTS7 MUC5AC MUC6 RASGRP2	2.34e-04	189	104	6	2300_UP
Drug	5707885; Down 200; 50uM; PC3; HT_HG-U133A	GPR137 PRR36 ARTN SRCAP HIVEP3 MEGF8	2.47e-04	191	104	6	6390_DN
Drug	Disulfiram [97-77-8]; Up 200; 13.4uM; PC3; HT_HG-U133A	TBKBP1 ARTN SRCAP PRDM2 HIVEP3 RASGRP2	2.47e-04	191	104	6	5729_UP
Drug	thioridazine hydrochloride; Down 200; 10uM; PC3; HT_HG-U133A	GPR137 MAPT TTLL5 SRCAP HIVEP3 BAHCC1	2.47e-04	191	104	6	4454_DN
Drug	3-Acetylcoumarin [3949-36-8]; Down 200; 21.2uM; MCF7; HT_HG-U133A	B4GALT2 GPR137 PRR36 MUC5B HES2 MMP9	2.54e-04	192	104	6	3382_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; HL60; HT_HG-U133A	PRDM2 HIVEP3 IGFBP7 EIF4G1 QSER1 MMP9	2.54e-04	192	104	6	2450_DN
Drug	Flunisolide [3385-03-3]; Up 200; 9.2uM; PC3; HT_HG-U133A	GPR137 MYO9B SH3D21 PRDM2 KLF13 HSF1	2.54e-04	192	104	6	4303_UP
Drug	Norgestrel-(-)-D [797-63-7]; Up 200; 12.8uM; PC3; HT_HG-U133A	MYO9B MUC5B MEGF8 A4GALT HSF1 MUC5AC	2.62e-04	193	104	6	3708_UP
Drug	17-AAG; Down 200; 1uM; PC3; HT_HG-U133A	GPR137 C15orf39 HIVEP3 MEGF8 KLF13 ZNF358	2.62e-04	193	104	6	5919_DN
Drug	Bromperidol [10457-90-6]; Up 200; 9.6uM; MCF7; HT_HG-U133A	MYO9B ARTN SRCAP HIVEP3 ZCCHC14 BAHCC1	2.62e-04	193	104	6	2872_UP
Drug	Amprolium hydrochloride [137-88-2]; Down 200; 12.6uM; PC3; HT_HG-U133A	TBKBP1 MAPT ARTN USP20 KLF13 INO80B	2.62e-04	193	104	6	4241_DN
Drug	Rilmenidine hemifumarate [54187-04-1]; Down 200; 8.4uM; PC3; HT_HG-U133A	GPR137 MAPT SRCAP USP20 LRP3 QSER1	2.62e-04	193	104	6	5107_DN
Drug	Phenazopyridine hydrochloride [136-40-3]; Down 200; 16uM; PC3; HT_HG-U133A	GPR137 PEX6 SRCAP MAP1S LRP3 INO80B	2.62e-04	193	104	6	5758_DN
Drug	Retrorsine [480-54-6]; Down 200; 11.4uM; HL60; HT_HG-U133A	B4GALT2 TTLL5 SRCAP LRP3 PIK3R5 RASGRP2	2.62e-04	193	104	6	2129_DN
Drug	PF-00562151-00 [351320-12-2]; Up 200; 10uM; MCF7; HT_HG-U133A	PRR36 FOSL1 ZCCHC14 SLC16A5 MUC5AC RASGRP2	2.62e-04	193	104	6	6868_UP
Drug	thiazolidinedione	NCOA6 PPRC1 APOH FOSL1 HIVEP3 PKD1 WNK4	2.66e-04	274	104	7	CID000005437
Drug	Epiandrosterone [481-29-8]; Up 200; 13.8uM; PC3; HT_HG-U133A	ARTN APOH HIVEP3 HSF1 INO80B RASGRP2	2.69e-04	194	104	6	4626_UP
Drug	Isoetharine mesylate salt [7279-75-6]; Down 200; 12uM; HL60; HT_HG-U133A	PEX6 IGFBP7 LRP3 INO80B RASGRP2 BAHCC1	2.69e-04	194	104	6	2711_DN
Drug	Dirithromycin [62013-04-1]; Up 200; 4.8uM; MCF7; HT_HG-U133A	ARTN SRCAP HES2 SH3D21 ZNF358 BAHCC1	2.69e-04	194	104	6	2863_UP
Drug	5252917; Up 200; 14uM; MCF7; HT_HG-U133A_EA	TTLL5 PEX6 SRCAP ZCCHC14 ROBO3 RASGRP2	2.69e-04	194	104	6	828_UP
Drug	Methyl benzethonium chloride [25155-18-4]; Down 200; 8.6uM; PC3; HT_HG-U133A	MAPT MYO9B ARTN ZNF358 LRP3 INO80B	2.69e-04	194	104	6	4325_DN
Drug	rapamycin, Streptomyces hygroscepicus; Down 200; 0.1uM; PC3; HT_HG-U133A	NID2 TBKBP1 DISC1 ARTN APOH ADAMTS7	2.76e-04	195	104	6	5980_DN
Drug	Cefepime hydrochloride [123171-59-5]; Up 200; 7.4uM; HL60; HT_HG-U133A	SH3D21 SLC16A5 ROBO3 MUC6 INO80B RASGRP2	2.76e-04	195	104	6	6159_UP
Drug	(S)-propranolol hydrochloride [4199-10-4]; Down 200; 13.6uM; MCF7; HT_HG-U133A	PRR36 C15orf39 ARTN SRCAP INO80B BAHCC1	2.76e-04	195	104	6	3523_DN
Drug	Dapsone [80-08-0]; Down 200; 16.2uM; PC3; HT_HG-U133A	GPR137 NID2 MAPT TTLL5 NFATC1 INO80B	2.76e-04	195	104	6	5078_DN
Drug	Isosorbide dinitrate [87-33-2]; Down 200; 17uM; MCF7; HT_HG-U133A	MYO9B TTLL5 ARTN ZCCHC14 A4GALT ROBO3	2.76e-04	195	104	6	4742_DN
Drug	Ethacrynic acid [58-54-8]; Up 200; 13.2uM; MCF7; HT_HG-U133A	ARTN FOSL1 IGFBP7 ADAMTS7 ZNF358 PIK3R5	2.76e-04	195	104	6	3181_UP
Drug	Nifedipine [21829-25-4]; Up 200; 11.6uM; MCF7; HT_HG-U133A	GPR137 TBKBP1 PRDM2 FOSL1 HIVEP3 RASGRP2	2.76e-04	195	104	6	6006_UP
Drug	Mephenytoin [50-12-4]; Down 200; 18.4uM; MCF7; HT_HG-U133A	GPR137 MYO9B TTLL5 HIVEP3 ZCCHC14 A4GALT	2.76e-04	195	104	6	3580_DN
Drug	Piracetam [7491-74-9]; Up 200; 28.2uM; MCF7; HT_HG-U133A	TBKBP1 MYO9B HIVEP3 ZCCHC14 MAP1S BAHCC1	2.76e-04	195	104	6	2861_UP
Drug	Enilconazole [35554-44-0]; Up 200; 13.4uM; PC3; HT_HG-U133A	SEMA6C TBKBP1 MAPT ARTN PRDM2 INO80B	2.76e-04	195	104	6	5113_UP
Drug	Salsolinol hydrobromide [38221-21-5]; Up 200; 15.4uM; PC3; HT_HG-U133A	MUC5B APOH IGFBP7 NFATC1 MICAL2 HSF1	2.76e-04	195	104	6	4232_UP
Drug	Finasteride [98319-26-7]; Down 200; 10.8uM; PC3; HT_HG-U133A	GPR137 MYO9B ARTN HSF1 INO80B CCN3	2.76e-04	195	104	6	4300_DN
Drug	Acacetin [480-44-4]; Down 200; 14uM; PC3; HT_HG-U133A	GPR137 TTLL5 ARTN SRCAP MMP9 INO80B	2.76e-04	195	104	6	4324_DN
Drug	Cephalexin monohydrate [23325-78-2]; Up 200; 11uM; HL60; HT_HG-U133A	PEX6 PRDM2 SLC16A5 KLF13 MICAL3 RASGRP2	2.76e-04	195	104	6	1273_UP
Drug	Flunisolide [3385-03-3]; Down 200; 9.2uM; MCF7; HT_HG-U133A	GPR137 PRR36 ARTN SRCAP LRP3 HSF1	2.76e-04	195	104	6	3923_DN
Drug	Thiocolchicoside [602-41-5]; Up 200; 7uM; MCF7; HT_HG-U133A	TBKBP1 MYO9B TTLL5 MUC5B SRCAP MUC5AC	2.76e-04	195	104	6	2875_UP
Drug	Acenocoumarol [152-72-7]; Up 200; 11.4uM; MCF7; HT_HG-U133A	HES2 ZCCHC14 IGFBP7 KLF13 ZNF358 MUC5AC	2.84e-04	196	104	6	2240_UP
Drug	0179445-0000 [211246-22-9]; Down 200; 1uM; PC3; HT_HG-U133A	GPR137 MYO9B USP20 HIVEP3 INO80B BAHCC1	2.84e-04	196	104	6	4292_DN
Drug	Methylhydantoin-5-(D) [55147-68-7]; Down 200; 35uM; MCF7; HT_HG-U133A	PRR36 MYO9B ARTN HIVEP3 MUC5AC BAHCC1	2.84e-04	196	104	6	3333_DN
Drug	(1)-Nipecotic acid [498-95-3]; Up 200; 31uM; MCF7; HT_HG-U133A	GPR137 NID2 PRDM2 HIVEP3 MUC6 CCN3	2.84e-04	196	104	6	5999_UP
Drug	haloperidol; Down 200; 10uM; MCF7; HT_HG-U133A	PRR36 SRCAP ZCCHC14 QSER1 INO80B BAHCC1	2.84e-04	196	104	6	5604_DN
Drug	alpha-estradiol; Up 200; 0.01uM; MCF7; HT_HG-U133A_EA	B4GALT2 PRR36 DISC1 TTLL5 MUC5B QSER1	2.84e-04	196	104	6	990_UP
Drug	Hymecromone [90-33-5]; Up 200; 22.8uM; PC3; HT_HG-U133A	TTLL5 ARTN HES2 HIVEP3 ZNF358 MMP9	2.84e-04	196	104	6	4623_UP
Drug	Benzonatate [104-31-4]; Down 200; 6.6uM; MCF7; HT_HG-U133A	PRR36 MYO9B ARTN MAP1S QSER1 MAST3	2.84e-04	196	104	6	1679_DN
Drug	Etilefrine hydrochloride [534-87-2]; Down 200; 18.4uM; MCF7; HT_HG-U133A	SRCAP HIVEP3 QSER1 ROBO3 HSF1 MUC6	2.84e-04	196	104	6	4415_DN
Drug	Metergoline [17692-51-2]; Down 200; 10uM; PC3; HT_HG-U133A	GPR137 TTLL5 ZNF358 LRP3 MICAL3 QSER1	2.84e-04	196	104	6	6744_DN
Drug	(-)-Isoproterenol hydrochloride [5984-95-2]; Up 200; 16.2uM; MCF7; HT_HG-U133A	HES2 MAP1S SLC16A5 ROBO3 MUC5AC MUC6	2.84e-04	196	104	6	3571_UP
Disease	late onset Parkinson's disease (is_implicated_in)	MAPT ATXN8OS EIF4G1	6.49e-06	11	102	3	DOID:0060892 (is_implicated_in)
Disease	autosomal recessive nonsyndromic deafness 16 (implicated_via_orthology)	STRC STRCP1	1.18e-05	2	102	2	DOID:0110471 (implicated_via_orthology)
Disease	HLA class II histocompatibility antigen, DM alpha chain measurement	IGHA1 IGHG3	3.54e-05	3	102	2	EFO_0801684
Disease	glaucoma (is_marker_for)	PTPN11 MMP9 MUC5AC	4.38e-05	20	102	3	DOID:1686 (is_marker_for)
Disease	reticulocyte count	NCOA6 MAPT MYO9B RREB1 PTPN11 DCAF10 KLF13 ZC3H4 MICAL2 A4GALT PKD1 FHDC1 NOTCH4	6.48e-05	1045	102	13	EFO_0007986
Disease	di-N-acetylchitobiase measurement	IGHA2 IGHG3	7.07e-05	4	102	2	EFO_0801524
Disease	cholangiocarcinoma (is_marker_for)	MUC5B MMP9 MUC5AC MUC6	7.29e-05	64	102	4	DOID:4947 (is_marker_for)
Disease	interstitial lung disease	MAPT MUC5B MUC5AC NOTCH4	8.73e-05	67	102	4	EFO_0004244
Disease	antiphospholipid antibody measurement	SGIP1 APOH MICAL3	8.73e-05	25	102	3	EFO_0005200
Disease	mucinous adenocarcinoma (is_marker_for)	MUC5AC MUC6	1.18e-04	5	102	2	DOID:3030 (is_marker_for)
Disease	beta-sarcoglycan measurement	IGHA2 IGHG3	1.76e-04	6	102	2	EFO_0801422
Disease	COVID-19 symptoms measurement	MAPT MUC5B MUC5AC	2.42e-04	35	102	3	EFO_0600019
Disease	stroke, response to clopidogrel, cardiovascular event measurement	WFDC1 MICAL2	2.46e-04	7	102	2	EFO_0000712, EFO_0006919, GO_1903493
Disease	Neurodevelopmental Disorders	SRCAP HIVEP3 PTPN11 ZC3H4	3.10e-04	93	102	4	C1535926
Disease	pancreatic cancer (is_marker_for)	ARTN MMP9 MUC5AC MUC6	4.25e-04	101	102	4	DOID:1793 (is_marker_for)
Disease	Parkinson disease, late-onset	MAPT ATXN8OS	5.23e-04	10	102	2	cv:C3160718
Disease	PARKINSON DISEASE, LATE-ONSET	MAPT ATXN8OS	5.23e-04	10	102	2	168600
Disease	Holoprosencephaly sequence	TGIF1 FOXH1	5.23e-04	10	102	2	cv:C0079541
Disease	pulmonary fibrosis	MUC5B MUC5AC	6.38e-04	11	102	2	EFO_0009448
Disease	PARKINSON DISEASE, LATE-ONSET	MAPT ATXN8OS	7.64e-04	12	102	2	C3160718
Disease	intracranial aneurysm (is_implicated_in)	PKD1 MMP9	7.64e-04	12	102	2	DOID:10941 (is_implicated_in)
Disease	dementia (is_implicated_in)	MAPT NOTCH4	7.64e-04	12	102	2	DOID:1307 (is_implicated_in)
Disease	C-reactive protein measurement	SEMA6C NCOA6 SGIP1 DGKZ APOH RREB1 USP20 FOSL1 PKD1 MICAL3 QSER1 CCN3	9.38e-04	1206	102	12	EFO_0004458
Disease	pulse pressure measurement	SGIP1 RREB1 SRCAP ZNF831 ARHGEF25 HIVEP3 TGIF1 FNDC1 MEGF8 PKD1 ROBO3 CCDC157 CCN3	1.02e-03	1392	102	13	EFO_0005763
Disease	idiopathic pulmonary fibrosis	TTYH1 MUC5B MUC5AC	1.02e-03	57	102	3	EFO_0000768
Disease	Alzheimer's disease (implicated_via_orthology)	MAPT HIVEP3 NOTCH4	1.02e-03	57	102	3	DOID:10652 (implicated_via_orthology)
Disease	gastric ulcer (implicated_via_orthology)	MUC5AC MUC6	1.05e-03	14	102	2	DOID:10808 (implicated_via_orthology)
Disease	ventricular septal defect (is_implicated_in)	NFATC1 MMP9	1.05e-03	14	102	2	DOID:1657 (is_implicated_in)
Disease	serum albumin measurement	APOH PTPN11 FAM117A IGHA1 KLF13 IGHA2 MICAL3 NOTCH4	1.05e-03	592	102	8	EFO_0004535
Disease	Alobar Holoprosencephaly	TGIF1 FOXH1	1.21e-03	15	102	2	C0431363
Disease	pancreatic ductal carcinoma (is_marker_for)	MUC5B MMP9 MUC5AC	1.25e-03	61	102	3	DOID:3587 (is_marker_for)
Disease	cystic fibrosis (is_marker_for)	MUC5B MMP9 MUC5AC	1.31e-03	62	102	3	DOID:1485 (is_marker_for)
Disease	ceramide measurement	FOXN1 TTLL5 CD320 MICAL2 A4GALT	1.37e-03	235	102	5	EFO_0010222
Disease	Lobar Holoprosencephaly	TGIF1 FOXH1	1.38e-03	16	102	2	C0431362
Disease	Semilobar Holoprosencephaly	TGIF1 FOXH1	1.38e-03	16	102	2	C0751617
Disease	Holoprosencephaly	TGIF1 FOXH1	1.56e-03	17	102	2	C0079541
Disease	sinusitis (is_marker_for)	MUC5B MMP9	1.75e-03	18	102	2	DOID:0050127 (is_marker_for)
Disease	mean arterial pressure	SGIP1 MYO9B DGKZ ZNF831 HIVEP3 PTPN11 BAHCC1	1.76e-03	499	102	7	EFO_0006340
Disease	mean reticulocyte volume	MAPT MYO9B PPRC1 C15orf39 TGIF1 PTPN11 FAM117A KLF13 TONSL	1.82e-03	799	102	9	EFO_0010701
Disease	eosinophil count	CARMIL2 INAFM1 MAPT APOH FOSL1 HIVEP3 FNDC1 PTPN11 MUC5AC PIK3R5 NOTCH4 MAST3 BAHCC1	1.85e-03	1488	102	13	EFO_0004842
Disease	kidney disease (biomarker_via_orthology)	NFATC1 MMP9	2.38e-03	21	102	2	DOID:557 (biomarker_via_orthology)
Disease	gastric ulcer (biomarker_via_orthology)	MMP9 MUC5AC	2.38e-03	21	102	2	DOID:10808 (biomarker_via_orthology)
Disease	Parkinson disease	MAPT ATXN8OS	2.61e-03	22	102	2	cv:C0030567
Disease	alkaline phosphatase measurement	MAPT RREB1 HIVEP3 TGIF1 PTPN11 NFATC1 TONSL PKD1 MICAL3 MMP9	2.72e-03	1015	102	10	EFO_0004533
Disease	Sjogren's syndrome (is_marker_for)	MMP9 MUC5AC	3.11e-03	24	102	2	DOID:12894 (is_marker_for)
Disease	systemic scleroderma (is_implicated_in)	MMP9 NOTCH4	3.11e-03	24	102	2	DOID:418 (is_implicated_in)
Disease	serum alanine aminotransferase measurement	DISC1 PEX6 APOH PTPN11 ADAMTS7 KLF13 ZC3H4 NOTCH4 MAST3	3.19e-03	869	102	9	EFO_0004735
Disease	Cerebral Astrocytoma	PTPN11 MMP9	3.37e-03	25	102	2	C0750935
Disease	Intracranial Astrocytoma	PTPN11 MMP9	3.37e-03	25	102	2	C0750936
Disease	Astrocytoma	PTPN11 MMP9	3.37e-03	25	102	2	C0004114
Disease	Grade I Astrocytoma	PTPN11 MMP9	3.37e-03	25	102	2	C1704230
Disease	Subependymal Giant Cell Astrocytoma	PTPN11 MMP9	3.37e-03	25	102	2	C0205768
Disease	Mixed oligoastrocytoma	PTPN11 MMP9	3.37e-03	25	102	2	C0547065
Disease	colon adenocarcinoma (is_marker_for)	FOSL1 MMP9	3.37e-03	25	102	2	DOID:234 (is_marker_for)
Disease	Pilocytic Astrocytoma	PTPN11 MMP9	3.37e-03	25	102	2	C0334583
Disease	Juvenile Pilocytic Astrocytoma	PTPN11 MMP9	3.37e-03	25	102	2	C0280783
Disease	Diffuse Astrocytoma	PTPN11 MMP9	3.37e-03	25	102	2	C0280785
Disease	Childhood Cerebral Astrocytoma	PTPN11 MMP9	3.37e-03	25	102	2	C0338070
Disease	feeling nervous measurement	NCOA6 ZCCHC14 NOTCH4	3.44e-03	87	102	3	EFO_0009597

Protein segments in the cluster

Peptide	Gene	Start	Entry
CCRPPEPPGSKIPSP	TTYH1	71	Q9H313
PTPPPRPSAPCTLNV	BAHCC1	1006	Q9P281
LPGPTAPTLPPCPDS	B4GALT2	86	O60909
SPPVSPTPKTPPCQA	ARHGEF25	556	Q86VW2
SPELPVCAPIICPPP	APOH	131	P02749
CPTLTPPTPPSHGPT	A4GALT	61	Q9NPC4
PGPPSPGQSPSPCRT	CARMIL2	1311	Q6F5E8
CPSNPGSPLPPASPR	FAM117A	401	Q9C073
TPPCCLPQIPGVTTP	EIF4EBP3	56	O60516
LSPCPPTRSPPPSTL	CBLL2	396	Q8N7E2
QPCTSPPRQPCTSPP	CCDC157	676	Q569K6
SCSPGCGPEVPPTPP	DISC1	186	Q9NRI5
GPCCSRPPPAPASPR	DISP2	1201	A7MBM2
PTPTCPTPELGSPLP	CDAN1	266	Q8IWY9
PPACEHLPRPPTETP	ADAMTS7	921	Q9UKP4
VSSTPTPTPCPPQPL	MUC5B	5276	Q9HC84
TFCPPPLPKPSSTTP	QSER1	1186	Q2KHR3
PLPKPPVPSAGSCEP	KIRREL3-AS3	111	Q8N7Y1
TPPECLLTPLPPSAP	NPIPB12	341	F8W0I5
PPPSPPCSCSREECP	FHDC1	41	Q9C0D6
PTAPPTVCPTGPPTV	MMP9	461	P14780
GVCVPCMPPTTPQPP	MUC6	1191	Q6W4X9
CMPPTTPQPPTTPQL	MUC6	1196	Q6W4X9
STPPPSPLPICSQPQ	MICAL3	1251	Q7RTP6
TPPPVQPPILTITCP	MAP1S	156	Q66K74
MPLAPPPTSCPQCPS	FOXH1	291	O75593
SPTSPTSCTPPPRPP	RASGRP2	391	Q7LDG7
EPASAPVPSPPSPPC	HES2	151	Q9Y543
PGPSPPHPRPLCQVC	GPR137	371	Q96N19
PSCCRQPPPAGPPVE	ATXN8OS	71	P0DMR3
PPPGSRPVSQPCCRP	ARTN	176	Q5T4W7
PPPPGLPCPCTGVSD	CD320	101	Q9NPF0
PPSCSSLQPPDPPAS	GJD4	341	Q96KN9
SPFLPPPPPVTDCSQ	NHSL1	951	Q5SYE7
PPPPVTDCSQGSPLP	NHSL1	956	Q5SYE7
PPSPPPTSTPEKCLS	HSF1	361	Q00613
LCPESGDSSRPPPPP	PEX6	166	Q13608
TASAPGEPSPPSPPC	DCAF10	81	Q5QP82
PQPDPLPCSAVAPSP	HOXA5	96	P20719
SLCPSSPSPPLPPAT	NFATC1	841	O95644
SPSPPLPPATQEPTC	NFATC1	846	O95644
SSPPLPCPTPCHLLP	MEGF8	2051	Q7Z7M0
SPEPLGVCRNPPPPC	LRP3	741	O75074
TVGPTTPPAPCLPSP	MUC5AC	5131	P98088
DQSPLPPCTPTPPCA	PTPN11	556	Q06124
TCGPCEPASCPPLPP	IGFBP7	31	Q16270
TPPECLLTPLPPSAP	NPIPA2	326	E9PIF3
QTPTLAPDPCPPCPD	ADAMTSL5	351	Q6ZMM2
SPSGPPPRCSVPGCP	INO80B	301	Q9C086
PPCTSSPVVPSHPPV	NCOA6	1746	Q14686
TPPHCGPSPEPTQRP	NID2	1001	Q14112
GPICPDSPPSPDPTR	GRID2IP	646	A4D2P6
PPQCPGRCPATPPTC	CCN3	36	P48745
EVVPDSPCLPPTPCP	FCGBP	1421	Q9Y6R7
SPCLPPTPCPPGSED	FCGBP	1426	Q9Y6R7
DSPCLPPPTCPPGSE	FCGBP	2626	Q9Y6R7
PPPTCPPGSEGCIPS	FCGBP	2631	Q9Y6R7
GPPCPASCPSPAPLT	FCGBP	3161	Q9Y6R7
TTPTPTTPIPTCPPG	FNDC1	1501	Q4ZHG4
DVTVPCPVPSTPPTP	IGHA1	96	P01876
SPSTPPTPSPSCCHP	IGHA1	111	P01876
PGTPPCGDPSRSTPP	C19orf67	26	A6NJJ6
APPPACPSESPVPIA	EIF4G1	381	Q04637
PSPTTPCRSPAPDVP	MAST3	1116	O60307
CRLPPPAPEPTSPGA	KLF13	96	Q9Y2Y9
CPPKSPAQCLPPPSS	LCE3C	21	Q5T5A8
CPPQCSAPCPPPVSS	LCE5A	36	Q5TCM9
DVTVPCRVPPPPPCC	IGHA2	96	P01877
DTPPPCPRCPAPELL	IGHG3	151	P01860
PDLPTPTSPLPTSPC	DGKZ	761	Q13574
PTSPLPTSPCSPTPR	DGKZ	766	Q13574
SPCPEAAAPPPGPRT	GPRIN1	776	Q7Z2K8
CLPPPPTVPLVSGTP	PPRC1	936	Q5VV67
SPPAPCRPVPCISLS	FOSL1	191	P15407
SVPPVPCVPSVPCTP	KRT36	421	O76013
CCPKPEEATPSPSPP	MICAL2	761	O94851
SSPPPCPPVLTVATP	PRDM2	971	Q13029
SLCSGPPPPPAPTCR	PKD1	246	P98161
TPPECLLTPLPPSAP	NPIPB13	341	A6NJU9
GPQPSAPSPPCAARP	INAFM1	66	C9JVW0
QPPGPTTSSLPRPPC	OTOG	321	Q6ZRI0
TPPECLLTPLPPSAP	NPIPA7	326	E9PJI5
TPPECLLTPLPPSAP	NPIPA8	326	P0DM63
PPPCLENSSPPSRIP	PPP1R12C	491	Q9BZL4
TPEAPPPQPPSSERC	SH3D21	416	A4FU49
PPPHCFPPGPCLTET	FOXN1	576	O15353
TTPHLETPPCPAPCP	PRR36	776	Q9H6K5
PAPCPLQAPPSPLTT	PRR36	786	Q9H6K5
PSSPLQPLPPSPCVG	PRR23B	226	Q6ZRT6
NPRVPPPCPEPSSVS	PPP1R32	276	Q7Z5V6
PRASPCPPRASSCPP	SIMC1	211	Q8NDZ2
PSCVPTPRPACKPPA	OCSTAMP	466	Q9BR26
PPPSQIPPCSSPACT	SRCAP	2486	Q6ZRS2
IPPCSSPACTPPPAC	SRCAP	2491	Q6ZRS2
PIPPPCLTPSPERGS	NOTCH4	1966	Q99466
PPTSCPEGLPPVPLT	STRC	451	Q7RTU9
DSPVPCTPPALPPCA	C15orf39	466	Q6ZRI6
GSSCAPPPPPARCPQ	TGIF1	76	Q15583
CPPPPRTLPPGACQA	WFDC1	66	Q9HC57
KECPPPPPETPALGC	SLC16A5	201	O15375
SPGPGRQCPPPITPT	SPNS3	21	Q6ZMD2
ACPPPRSQTPSPPTD	PIK3R5	571	Q8WYR1
SEQPSPCPAPGPSLP	RREB1	966	Q92766
PATPLVPCRSTTPPP	SGIP1	446	Q9BQI5
TSPPLSPCPEPPSNS	TONSL	691	Q96HA7
PPPPPSCELSCLEGP	ROBO3	1086	Q96MS0
HSPCTPPDTLPRPPQ	HIVEP3	2306	Q5T1R4
PPPELACLPTPESTP	SEMA6C	691	Q9H3T2
PSSPAVCPEPPSSPK	MAPT	426	P10636
PPSPRSSSPCRTPEP	USP20	366	Q9Y2K6
TPSPPPCSPDARPAT	ZC3H4	26	Q9UPT8
TLPQPPPATCPPGAL	ZNF598	601	Q86UK7
PQPAPPPPGCIVCTS	ZCCHC14	776	Q8WYQ9
PPTSCPEGLPPVPLT	STRCP1	451	A6NGW2
PTCPAPPARDQPAPT	ZNF831	6	Q5JPB2
SNLSPPPAPAPPCTD	TBKBP1	181	A7MCY6
QCPSPSPPARAAPPC	TBKBP1	346	A7MCY6
SPPARAAPPCPPCQS	TBKBP1	351	A7MCY6
GPIFPITSPPCHPSP	WNK4	826	Q96J92
PTPTPPTCPVSTTGP	TSHZ1	156	Q6ZSZ6
VPPPSSCASLVPKPP	TTLL5	1216	Q6EMB2
VCTPLPTPQPTPPCS	KIAA0586	1036	Q9BVV6
PDPNPVSCPDPCSPT	ZNF358	526	Q9NW07
PPCSGAATPTPSLPP	SLC8A2	16	Q9UPR5
LPCPGAPTPSPLPTV	MYO9B	2026	Q13459
PPSPCPTPRSGPSPC	GRIN2C	931	Q14957
PTPRSGPSPCLPTPD	GRIN2C	936	Q14957